Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Oct 4.
Published in final edited form as: Nanoscale. 2015 Jan 14;7(2):814–824. doi: 10.1039/c4nr04834b

Receptor-mediated membrane adhesion of lipid-polymer hybrid (LPH) nanoparticles studied by dissipative particle dynamics simulations

Zhenlong Li 1,, Alemayehu A Gorfe 1,
PMCID: PMC5048752  NIHMSID: NIHMS818438  PMID: 25438167

Abstract

Lipid–polymer hybrid (LPH) nanoparticles represent a novel class of targeted drug delivery platforms that combine the advantages of liposomes and biodegradable polymeric nanoparticles. However, the molecular details of the interaction between LPHs and their target cell membranes remain poorly understood. We have investigated the receptor-mediated membrane adhesion process of a ligand-tethered LPH nanoparticle using extensive dissipative particle dynamics (DPD) simulations. We found that the spontaneous adhesion process follows a first-order kinetics characterized by two distinct stages: a rapid nanoparticle–membrane engagement, followed by a slow growth in the number of ligand–receptor pairs coupled with structural re-organization of both the nanoparticle and the membrane. The number of ligand–receptor pairs increases with the dynamic segregation of ligands and receptors toward the adhesion zone causing an out-of-plane deformation of the membrane. Moreover, the fluidity of the lipid shell allows for strong nanoparticle–membrane interactions to occur even when the ligand density is low. The LPH–membrane avidity is enhanced by the increased stability of each receptor–ligand pair due to the geometric confinement and the cooperative effect arising from multiple binding events. Thus, our results reveal the unique advantages of LPH nanoparticles as active cell-targeting nanocarriers and provide some general principles governing nanoparticle–cell interactions that may aid future design of LPHs with improved affinity and specificity for a given target of interest.

1. Introduction

Lipid–polymer hybrid (LPH) nanoparticles were first reported in 2008 as a class of promising next-generation nanoscale drug delivery platforms.1 Despite continuous improvements in their synthesis, drug loading/release and cellular uptake profiles,17 the microscopic details of their interaction with cell membranes during active targeting remain elusive.7 In this work, we have investigated the receptor-mediated membrane adhesion of a model LPH using dissipative particle dynamics (DPD) simulations.

The adhesion of ligand-tethered nanoparticles onto receptor-bearing cell surfaces represents a critical step for receptor-targeting nanoparticles to recognize and enter pathogenic cells.8,9 Understanding the molecular details of this process is necessary for the assessment of nanoparticle efficacy and structural optimization. Experimental techniques such as surface plasmon resonance (SPR) and fluorescence spectroscopy have been used to characterize the adhesion process in vitro by monitoring the adhesion and detachment events.1014 However, the limited resolution of these techniques does not allow for extracting individual adhesion events.10 Another major challenge lies in the difficulty to predict the adhesion strength based on the ligand–receptor binding affinity due to lack of information on the equilibrium adhesion structure.12

A variety of theoretical and computational models have been developed to interpret the mechanism of nanoparticle–membrane adhesion observed in macroscopic experimentations. For example, Ghaghada et al. developed a mathematical model to characterize folate-tethered liposomes that target folate receptors.15 Similarly, Decuzzi et al. examined the active targeting of diseased microvasculature and proposed a number of geometrical and biological considerations that need to be taken into account during rational designing of nanoparticles.16,17 Using multi-scale computations, Radhakrishnan and colleagues estimated the free energy landscape of nanoparticle adhesion onto endothelial cells,1820 while Dormidontova and colleagues evaluated the influence of various nanoparticle surface structural parameters on the adhesion strength and specificity.2123 These studies provided a theoretical framework for optimizing the nanoparticle structure based on nanoparticle–cell interactions. Our focus here is to characterize the equilibrium adhesion mode of LPH nanoparticles.

Electron microscopy (EM) and dynamic light scattering (DLS) studies have shown that various LPH nanoparticles share a spherical core–shell–corona structure1,6 with a polymeric core, which consists of hydrophobic biodegradable polymers, functioning as the major drug reservoir. The core is covered by a lipid monolayer shell, in which a small fraction of lipids are covalently attached to the headgroup with hydrophilic polymers that form the corona. The distal end of the corona chain can be functionalized by targeting ligands that bind to specific cell-surface targets.1,2 Compared to traditional lipid-based or polymer-based nanoparticles, LPH nanoparticles have unique structural features that influence their interaction with cell membranes. For example, the lipid shell may facilitate re-organization of the polymer tethers and ligands on the nanoparticle surface during adhesion. Furthermore, the core is an amorphous polymeric matrix that is less prone to deformation than the liquid interior of liposomes. These features make it difficult to directly apply generalized membrane adhesion models to LPH nanoparticles.

From a thermodynamic perspective, the system free energy of a nanoparticle–membrane assembly should decrease upon a ligand–receptor association during adhesion.15,24 At the same time, the ligand–receptor association introduces a constraint on the polymer tether ends and reduces the conformational freedom of the entire tether, which leads to entropic penalty. Furthermore, formation of multiple ligand–receptor interactions may also trigger membrane curvature.14 The adhesion process is thus determined by the competition between these factors and involves a wide range of interactions. We chose DPD to circumvent the time and lengthscale limitations associated with atomistic models. DPD is a mesoscopic particle-based simulation approach25,26 that has been widely used to study lipid membranes, membrane proteins and polymers.22,2729 It allows for accurate modeling of hydrodynamic interactions and reproduces the static and dynamic properties of polymer chains in solution and melt,30,31 and has been used to study receptor-mediated membrane adhesion of polymeric micelles22 and cell–cell adhesion processes.28

2. Method

In a DPD simulation, the system is coarse-grained into interacting beads and evolves based on Newton’s mechanics.25,26 A detailed description of the method and parameterization can be found in our previous publication.32

Our model accounts for the molecular-level structure of the ligand-tethered LPH, the lipid membrane in which multiple transmembrane receptors are embedded, and the solvent environment (Fig. 1). We used reduced DPD units for all variables, with particle mass m0, diameter d0 and time t0 taken to be the mass, length and time unit, respectively. The pairwise conservative interaction parameters used for each pair are summarized in Table 1. The interaction parameter between W beads is aWW = 25kBT/d0. Altogether, an average number density of 3 for all beads ensures the ability to reproduce the compressibility of water at room temperature.26 For the lipid molecules, the tail-water repulsive parameter (aTlW = 75kBT/d0) is made larger than that of headgroup-water (aHlW = 35kBT/d0), reflecting the amphiphilic nature of lipids. For the tether chains, the repulsive parameter with water (aTeW) is the same as aWW as the chain is hydrophilic. For the core-forming chain, the repulsive parameter with water is larger than aWW to reflect the hydrophobic nature of the polymer.

Fig. 1.

Fig. 1

DPD models: (a) models of the lipid, polymer chain, and receptor. The lipid headgroup beads (labeled 1–4) are in green and tail beads (5–12) are in cyan. For the polymer tether chain, the green bead and the yellow bead represent the lipid headgroup bead 1 and the ligand bead, respectively. Core (blue) represents the core-forming chain of the LPH nanoparticle. Note that the actual number of beads is 1000 for this chain. For the receptor, the active site is in light red, the linker in green and the transmembrane segment in cyan. Molecules are not to scale. (b) Top and lateral side views of a lipid bilayer membrane containing 2306 lipids and 100 receptors. The color scheme is the same as in (a).

Table 1.

DPD conservative interaction parametersa

Hl Tl W Te Lig Co Hr TMr Ar
Hl 35 50 35 50 50 75 35 75 75
Tl 20 75 75 75 27 50 24 75
W 25 25 25 75 35 75 75
Te 25 25 75 35 75 75
Lig 75 75 25 75 aLigAr
Co 25 75 75 75
Hr 75 75 75
TMr 75 75
Ar 75
a

aLigArrepresents the receptor–ligand repulsive parameter that was varied (6, 5, 3, 1kBT) in different simulations to tune the receptor– ligand binding strength.

Hl: lipid headgroup, Tl: lipid tail, W: water, Te: tether chain, Lig: ligand, Co: core-forming chain, Hr: hydrophilic linker of the receptor, TMr: hydrophobic transmembrane segment of the receptor, Ar: active site of the receptor.

A. Model systems

(i) LPH nanoparticle

The LPH is made up of a core-forming polymer chain, unmodified lipids, and lipids with a hydrophilic polymer tether (Fig. 1a). Similar to our previous DPD study of lipid vesicles,33 a lipid molecule is modeled as a H4(T4)2 amphiphile, where H is the hydrophilic headgroup and T is the hydrophobic tail (see Fig. 1a). Adjacent beads are connected by a harmonic potential El,b = 1/2kl,b (rijbl,b1)2 where rij is the distance between two bonded beads. A force constant kl,b = 100kBT/d02 and an equilibrium bond length bl,b1 = d0 are used for all bonds except for the bond between beads 3 and 4, for which a shorter bond length bl,b2 = 0.8d0 is used. A harmonic potential El,a = 1/2kl,al − θl,0)2 is applied to all bond angles θl with a force constant kl,a = 40kBT to maintain chain rigidity. The equilibrium angle θl,0 is 120° for the bond angle between beads 2, 3 and 4, and 180° for all others.

Both the tether and core-forming chains are modeled as linear free-rotating chains (FRCs) (Fig. 1a). In each case, intrachain bonding interaction is modeled by a harmonic potential with a force constant kp,b = 100kBT and an equilibrium bond length bp,0 = 1.0d0. The angle between two adjacent bonds (θp) is restrained by a harmonic potential Ep,a = 1/2kanglep − θp,0)2 with a force constant kp,a = 50kBT and an equilibrium bond angle θp,0 = 109.5°. The number of beads for the tether (ntether) and the core (ncore) are 20 and 1000 respectively. One end of the tether is linked to a lipid headgroup (bead 1) using the same bond potential as that of the tether, while the distal end is modeled as a ligand bead (Lig) capable of forming reversible interaction with the active site of a membrane receptor (see below).

(ii) Lipid bilayer and receptor

The lipid model for the bilayer membrane is the same as that of the nanoparticle shell (Fig. 1). Following a previous DPD study on cell–cell adhesion receptors,28 a receptor is modeled as a cylindrical transmembrane protein (Fig. 1a). Specifically, the receptor molecule consists of 84 covalently linked beads evenly arranged in 12 layers along the bilayer normal. In each layer, the central bead is surrounded by 6 beads arranged in a hexagon of sides 0.875d0. The distance between two neighboring layers is 0.8d0. These geometric parameters are maintained by the harmonic bond and angle potential (krb = 100kBT and kra = 40kBT) applied on neighboring beads. The middle 6 layers are composed of hydrophobic beads (TMr) and represent the transmembrane segment. On each side of this segment are two layers of hydrophilic beads (Hr) that connect to a layer of hydrophilic beads (Ar) that bear the active site for ligand binding. The reason for this design of active sites on both ends is to enable binding of nanoparticles to either side of the membrane. The intra- and inter-molecular interaction parameters are set to 75kBT/d0 for all receptor beads (Table 1) to maintain the cylindrical shape and prevent lateral self-aggregation.

(iii) Receptor–ligand interaction

Similar to a previous DPD study on the cell adhesion kinetics of ligand-tethered polymeric micelles,22 the reversible binding between a ligand and an active site of the receptor is modeled by the differential interactions of the ligand with the active site on the one hand and water on the other. Specifically, the repulsive interaction parameter between a ligand bead and an Ar bead (aLigAr) is made smaller than aLigW so that the ligand has a tendency to associate with a proximal Ar bead. The binding strength is tuned by the interaction parameter difference (Δa = aLigWaLigAr), or simply aLigAr since aLigW is kept constant (25kBT/d0). Based on a previous survey of experimental ligand–receptor binding affinities,34 a DPD study of micelle–membrane adhesion,22 and our test runs on nanoparticle–membrane adhesion probability, we determined a series of binding strengths (Δa = 19, 20, 22, 24kBT/d0) that can lead to adhesion. To avoid simultaneous association of multiple ligands with the same receptor, a large self-repulsive parameter (aLigLig = 75kBT/d0) and cutoff distance (rc = 2.0d0) are applied between ligand beads.

(iv) Water

Water molecules are represented by single beads (W).

B. System setup and simulation protocol

DPD simulations were conducted with the LAMMPS package35 and analyzed with VMD.36 The integration time interval Δt was set to 0.02(m0d02/kBT)1/2 for all simulations.

(i) Nanoparticle formation

The LPH nanoparticle was formed through self-assembly of model lipids and polymer chains in water. A core-forming polymer chain was first generated through a self-avoiding random walk and placed at the center of a 30d0 × 30d0 × 30d0 simulation box. 600 lipid molecules were then randomly placed around the core-forming polymer chain. Among them, 10% (60) are covalently attached with a hydrophilic polymer chain and a ligand at the headgroup. This surface grafting density was based on previous experimental reports on the optimal range of nanoparticle surface grafting density for a prolonged circulation time and limited toxicity.37 The system was then solvated and simulated with a periodic boundary condition at a constant volume and temperature (NVT, kBT = 1.0) for 2 000 000 timesteps (40 000t0). Coordinates were recorded every 100 timesteps (2t0) for data analysis.

(ii) Ligand association with the soluble form of the receptor

To study the association stability of a receptor–ligand pair in the absence of a polymer tether and the transmembrane segment of the receptor, we simulated the association of the soluble part of the receptor (i.e., the three layers including the active site and the linker) with the ligand, using a larger force constant (kra = 100kBT) for all the bond angle potentials to maintain the cylindrical shape. All other parameters remained the same as the nanoparticle–membrane simulations. At each Δa, one soluble receptor and one ligand were placed in a water box of 10d0 × 10d0 × 10d0 and simulated for 2 × 107 timesteps (4 × 105t0), saving coordinates every 100 timesteps (2t0).

(iii) Nanoparticle–membrane adhesion

A self-assembled bilayer of 288 lipids per leaflet from a previous study33 was used as the starting point for the lipid membrane. After 25 receptors were evenly inserted, the bilayer was equilibrated for 1 000 000 timesteps (20 000t0) at constant pressure and temperature (NPT, P = 23.88kBT/d03, kBT = 1.0) conditions to relax the bilayer to a nearly a tensionless state (bilayer surface tension close to zero). The bilayer was then duplicated in a 2 × 2 grid and equilibrated, yielding a larger bilayer of 2306 lipids and 100 receptors. The final membrane area is ~1679.4d02, hence the average number density of the receptor is ~0.06d0−2.To simulate the adhesion process, the membrane and the nanoparticle were placed in a 40.98d0 × 40.98d0 × 49.59d0 simulation box, with the bilayer normal being parallel to the z-axis. With PBC setting, the two surfaces of the bilayer were separated by the solvent with an average distance of ~43.3d0 along the z-axis. The nanoparticle was placed at the center of the solvent region so that its geometric center is equidistant (~21.7d0) from the two surfaces of the membrane. This setup allows for the nanoparticle to be far away from each surface in the beginning and interacts with only one side at any given time. The system was equilibrated using NVT simulation for 10 000 timesteps (200t0) applying position restraints along the z-axis to both the membrane lipid headgroups and the nanoparticle core using a soft harmonic potential of the force constant km = 5.0kBT. After equilibration, the position restraints were removed and NVT simulation was conducted for up to 1.2 × 105t0 to study the spontaneous adhesion process. For each Δa, 10 independent simulations were performed to improve sampling. Coordinates of the system were recorded every 1000 timesteps (2t0) for data analysis.

3. Results and discussion

During the adhesion simulations, equilibration was monitored by the time evolution of the number of receptor–ligand pairs and the distance between the LPH and the membrane center of masses (Fig. 4, disused later). Both show that the spontaneous adhesion process is complete at the time points indicated by the second dashed lines in Fig. 4, and the system is stabilized thereafter. We used that part of the trajectory for analyses of equilibrium proprieties.

Fig. 4.

Fig. 4

Time-evolution of N(t) and lnm. (a–d) Plots for binding strength Δa = 19 (a), 20 (b), 22 (c), and 24kBT (d). Both N(t) and lnm were averaged over 10 independent simulations. The blue line is a fitting curve of N(t) and the dashed line indicates the average separation distance calculated using the last 20 000t0 of lnm.

A. Equilibrium structure of the LPH nanoparticle

A visual inspection indicates that the LPH has a spherical core–shell–corona shape. The radial density profile of its constituents centered at the geometric center of the nanoparticle core (Fig. 2) shows that the polymeric core is about 4d0 in radius. The core includes a part of the tail region from the lipid shell, which is a monolayer of tightly packed lipids that protects the core from exposure to water. Based on the lipid headgroup distribution, the radius of the spherical shell is estimated to be 8.0d0. The corona is a dilute polymer brush tethered to the shell (Fig. 2b), with the distal end of the polymer extending up to ~16d0 from the nanoparticle center. The distribution of the tether length as measured by the end-to-end distance, ltether, is Gaussian and can be described by (eqn (1)):

P(ltether)=1σ2πexp((ltetherlmean)22σ2), (1)

with an average length lmean = 7.0d0 and standard deviation σ = 2.2d0 (Fig. 2b, inset). Based on the chain statistics of FRCs,38 the root mean square end-to-end distance <ltether2>1/2 can be calculated as (eqn (2)):

ltether21/2=ntetherbp,021cos(θp,0)1+cos(θp,0), (2)

which yields 6.3d0 using the tether bond number ntether = 20, equilibrium bond length bp,0 = 1.0d0 and bond angle θp,0 = 120° (see the Method section). This is slightly larger than lmean obtained from our simulation, indicating that the tethers are well solvated in the simulations.

Fig. 2.

Fig. 2

Equilibrium structure of the LPH nanoparticle. (a) Snapshot of the equilibrium structure with the same color code as Fig. 1. (b) Radial number density profile of different beads centered on the nanoparticle geometric center; the tether profile includes the ligand beads. Inset: probability distribution of the end-to-end distance (ltether) of the polymer tethers fitted with a Gaussian function.

B. Membrane adhesion is a two-stage process following first-order kinetics

In all nanoparticle–membrane adhesion simulations, the initial random motion of the nanoparticle in water triggers the formation of the first ligand–receptor contact, which is quickly followed by its adherence to one side of the membrane. This is illustrated in Fig. 3 using three representative snapshots for the initial, intermediate and final stages of a typical adhesion process for Δa = 24kBT. To quantitatively characterize this process, the average number of receptor–ligand contact N(t) and nanoparticle–membrane separation distance (dnm) are monitored over time t. A ligand and a receptor are defined as bound to each other if the ligand is within a cutoff distance of 1.0d0 from any Ar bead of the receptor. dnm was calculated as the vertical distance between the nanoparticle center of geometry and its projection onto the local bilayer mid-plane (defined by the average z position of lipid tail beads 8 and 12, see Fig. 3d). Fig. 4 shows the time-evolutions of N(t) and dnm for different Δa values. For all Δa, the adhesion process can be divided into two stages based on the time taken for dnm to stabilize (Fig. 4, left dashed line). In the first stage, the nanoparticle is quickly pulled towards the bilayer leading to a sharp rise in N(t). In the second stage, the nanoparticle maintains a constant distance from the bilayer surface while N(t) rises at a lower rate. The slow increase of N(t) in the second phase can be attributed to the steric effect of the bound tethers and reduced ligand concentration in the adhesion zone. More than half of the ligand–receptor interactions are formed during this second stage.

Fig. 3.

Fig. 3

Nanoparticle–membrane adhesion process. Snapshots from the simulation with Δa = 24kBT at (a) t = 0t0, (b) t = 20 000t0, and (c) t = 60 000t0. Color scheme is the same as in Fig. 1 and water is not shown for clarity. In b and c, receptor-bound ligands are highlighted in blue. (d) A schematic representation of the adhesion structure at equilibrium where dnm is the vertical separation distance between the nanoparticle and the membrane, ltether is the end-to-end distance of the polymer tethers. The Z-axis is along the bilayer normal with the geometric center of the nanoparticle as the origin. The R-axis is parallel to the bilayer plane with the projection of the nanoparticle center as the origin.

For all simulations, the plots of N(t) can be fitted with a pseudo-first-order kinetics (eqn (3)):

N(t)=Ne(1exp(kappt)) (3)

where Ne represents the equilibrium number of the receptor– ligand contacts and kapp is the apparent receptor–ligand association rate constant (Fig. 4 and Table 2). This is consistent with the membrane adhesion kinetics of ligand-tethered polymeric micelles observed in a previous DPD study.22 Although both Ne and kapp increase with Δa (Table 2), the approximate time needed to reach equilibrium (Fig. 4, right dashed line) decreases with Δa, indicating that kapp depends on Δa more strongly than it does on Ne.

Table 2.

Summary of curve fitting results of Fig. 4 and 8a

Δa/[kBT] Ne kapp/[10−5/t0] <dnm>/[d0] Dn [10−4d02/t0]
19 8.0 ± 0.3 5.1 ± 0.8 17.4 ± 0.3 8.28 ± 0.02
20 11.9 ± 0.2 5.1 ± 0.4 17.2 ± 0.3 7.36 ± 0.02
22 19.5 ± 0.3 7.5 ± 0.5 16.7 ± 0.2 5.45 ± 0.02
24 26.8 ± 0.3 8.7 ± 0.5 16.4 ± 0.2 4.94 ± 0.01
a

<dnm> is the average vertical separation distance (see Fig. 3d) between the nanoparticle geometric center and the bilayer mid-plane at equilibrium. Ne and kapp are fitting results of Fig. 4 using N(t) = Ne(1 − exp(−kappt)). Dn is the fitting result of Fig. 8 (after t = 500t0) using MSD = 4Dnt.

C. Lipid fluidity and tether extension enhance receptor–ligand interaction

The profiles of N(t) and dnm (Fig. 4) indicate that the simulations are well equilibrated within the last 20 000t0. Averaging over this portion of each trajectory yields an average dnm (<dnm>) of 16.4d0–17.4d0 that only slightly decreases with the increase of Δa (Fig. 4 and Table 2), whereas the average distance between the receptors’ active site and the bilayer mid-plane is ~4.0d0. Combining with the nanoparticle lipid shell radius of ~8.0d0 (see Fig. 2b and 3d), these yield 4.4d0 for the minimal distance between the lipid shell surface and the active site facing the nanoparticle. Below we discuss the equilibrium structure of the nanoparticle and the membrane with the help of a simplified schematic of the relative position of the nanoparticle and the membrane as displayed in Fig. 3d.

(i) Nanoparticle surface structural re-organization

It is expected that only ligands within certain distances from the membrane surface can bind to receptors, because the fixed tether length and nanoparticle–membrane separation distance would prevent some ligands from reaching the receptors. To characterize the distribution of receptor-bound ligands, we first calculated the number density profile of the ligand-tethered lipids (Fig. 5a) along the local bilayer normal (z-axis) (see Fig. 3d). We found that, for each Δa, the majority of the ligand-tethered lipids are on the side of the nanoparticle facing the membrane (Fig. 5b). In other words, the surface distribution of the ligand-tethered lipids is inhomogeneous and decreases sharply with the distance from the membrane surface. This suggests that LPH nanoparticles, similar to ligand-tethered liposomes,34 have the potential to enhance membrane adhesion by lateral re-organization of the lipid shell. Since the lateral diffusion of lipids in the lipid shell is influenced by the phase behavior of the lipid monolayer and the characteristics of the polymer tethers, these parameters can be tuned to facilitate the diffusion of tethered lipids towards the adhesion zone.

Fig. 5.

Fig. 5

Equilibrium structure of the nanoparticle surface on the membrane. (a) Density profiles of all (dashed line) and receptor-bound (solid line) ligand and lipids on the nanoparticle surface along the bilayer normal (z-axis, see Fig. 3d for illustration). (b) Average end-to-end distance of the tethers as a function of the vertical distance between their fixed ends and the nanoparticle geometric center. Each curve was calculated using the last 20 000t0 of adhesion simulations at different binding strengths (Δa = 19, 20, 22, 24kBT) and averaged over 10 independent simulations.

(ii) Tether extension

To determine the influence of membrane adhesion on the tether conformation, we calculated the average length <ltether> of the liganded tethers as a function of the z-position of their fixed end (i.e., the lipid headgroup bead 1, see Fig. 5b and 3d). That <ltether> is greater than lmean (see section 3.A) indicates that the liganded tethers are under a different level of stress than the unliganded tethers; and the farther away these tethers are from the bilayer surface the larger their extension. This is consistent with a previous biophysical study that concluded that semi-flexible tethers become extended when bound to a surface through receptor– ligand association.24 The linear correlation between <ltether> and z, and hence the distance between the fixed ends and their projections on the bilayer surface, seems to indicate that each ligand preferably binds to a receptor that faces its tether’s fixed end. The maximal tether length (10.5–11.0d0 at z = 0.0d0) is determined by the upper limit of the tether length in the free state (section 3.A, Fig. 2b inset) since, beyond lmean and until the tether reaches full extension, the entropic penalty is approximately proportional to24 <lmean2>. As dnm, the overall extension slightly decreases with Δa, and at larger Δa more tethers bind receptors; hence on average each tether contributes less to the total adhesion force required to overcome the hydrodynamic drag force exerted by the solvent on the nanoparticle.

(iii) Receptor re-distribution

In Fig. 6a, the number density profiles for the ligand-bound and all receptors around the projection of the nanoparticle center on the membrane (see Fig. 3d) are plotted for all binding strengths. One can see that the ligand-bound receptors are almost evenly distributed under the projection of the nanoparticle shells (R < 8.0d0). Due to the constraint imposed by the tether length, the density of the ligand-bound receptors decreases quickly after a distance equivalent to the maximum tether length, and the maximum extension is very similar for all Δa since it is mainly determined by the extension limit of the tethers. The receptor density at the adhesion region is greater than that of the surrounding region (Fig. 6a), indicating that adhesion induces receptor segregation.

Fig. 6.

Fig. 6

Equilibrium structure of the membrane. (a) Radial number density profile of all (dashed line) and ligand-bound (solid lines) receptors around the nanoparticle projection on the bilayer (R-axis, see Fig. 3d for illustration). (b) The average displacement of the bilayer mid-plane relative to the projection of the nanoparticle geometric center on the bilayer mid-plane as a function of the R-position. Data for different binding strengths (Δa = 19, 20, 22, 24kBT).

(iv) Bilayer deformation

Fig. 3c suggests that the bilayer experienced an out-of-plane deformation to accommodate the nanoparticle. We quantified this by calculating the average bilayer shape near the projection of the nanoparticle center (Fig. 6b) based on the average vertical displacement of the bilayer midplane (Δhz) along the R axis using the nanoparticle projection as the starting point (see Fig. 3d). The result shows that the high surface curvature of the nanoparticle induces local curvature on the bilayer, and this effect increases with Δa due to the tighter adhesion. Such a negative membrane curvature may facilitate internalization of the nanoparticle. Conversely, one can surmise that membrane adhesion of nanoparticles may be facilitated by a local negative membrane curvature.39

Taken together, the equilibrium adhesion mode is affected by steric effects at the adhesion zone, lipid mobility, and the elastic properties of the polymer tethers and the membrane. While lateral diffusion of lipids and receptors is thermally excited and costs marginal energy, tether extension and membrane bending would require the expenditure of elastic energy. The balance between these factors, and the number of receptor– ligand interaction pairs, determines the equilibrium structure of the adhesion zone.

D. Equilibrium dynamics of nanoparticle–membrane adhesion

At equilibrium, N(t) remains constant (Fig. 4) despite fluctuations in the receptor–ligand interactions. To characterize this fluctuation in more detail, we used a time-dependent autocorrelation function f(t) that monitors the breaking of receptor– ligand interaction pairs. In this function, we record the total number of receptor–ligand pairs at time tstart (A(tstart)) and the identity of each ligand and receptor involved in the binding. We then record the number of surviving receptor–ligand pairs at subsequent time steps t (A(t)), and calculate f(t) as (eqn (4)):

f(t)=A(t)A(tstart), (4)

where <> denotes ensemble averaging over different tstart. This function records the total fraction of receptor–ligand pairs that break over time. Fig. 7a shows that f(t) follows a first-order exponential decay at all binding strengths (eqn (5) and Table 2):

f(t)=1exp(tτ) (5)

where the characteristic time τ can be interpreted as the average residence time of a receptor–ligand pair. Clearly, τ increases with Δa since decay of f(t) slows down with Δa (Fig. 7b).

Fig. 7.

Fig. 7

Equilibrium dynamics of the nanoparticle–membrane adhesion. (a) Receptor–ligand disassociation f(t) and (b) average residence time. The membrane-bound state refers to the residence time obtained from fitting of the curves in (a) for different binding strengths (Δa = 19, 20, 22, 24kBT). The average residence time in solution was obtained from simulations of a single ligand and receptor pair (without the transmembrane part) in water, and standard deviation was calculated using time block averaging.

For comparison, we also calculated the average residence time of a receptor–ligand pair in the absence of the confinement imposed by the membrane and the tether by simulating a single receptor–ligand pair in solution (see the Method section) (Fig. 7b). Using the same distance criteria as in the complex nanoparticle–membrane system, a receptor-ligand pair in solution is defined to be in the bound state if they are within 1.0d0 of each other, and the average residence time is calculated by dividing the total time the pair spent in the bound state by the number of disassociation events during an extended time period. We found τ is larger in the membrane system for every Δa. An increase in the stability of the receptor–ligand pairs in the membrane can be understood from the decrease in the diffusion of receptor/ligand molecules and the co-operativity arising from the multivalent binding. The collective effect dampens the negative impact of the tether extension on the stability of receptor–ligand interactions.

The other dynamic feature of the adhesion process is the lateral drift of the nanoparticle on the membrane surface,22 which we have characterized based on the 2-dimensional (2D) mean squared displacement (MSD) of the nanoparticle (Fig. 8). The linear fitting of MSD curves (Fig. 7b, t > 500t0) yield the lateral diffusion coefficient Dn via the Einstein equation. We found that though Dn (4.94–8.28 × 10−4d02/t0, Table 2) decreases with the increase of Δa, in each case it is smaller by one or two orders of magnitude than the corresponding 2D diffusion coefficient of the unbound nanoparticle (1.48 × 10−3d02/t0), the receptor (2.75 × 10−3d02/t0)) in water, and lipids (1.58 × 10−2d02/t0) in the bilayer, respectively. Clearly, lateral diffusion of the nanoparticle is significantly reduced by membrane adhesion, and is likely dependent on the dynamics of receptor-ligand binding plus the extent of the membrane’s local negative curvature (Fig. 6d).

Fig. 8.

Fig. 8

MSD of the nanoparticle. 2D mean squared displacement (MSD) of the nanoparticle on the membrane. Dashed line indicates the starting time for linear fitting.

4. Conclusion

Motivated by the unique structure of self-assembled LPH nanoparticles and their potential as drug nanocarriers for active cell targeting,1,3 we have studied the membrane adhesion of a model LPH nanoparticle mediated by multivalent receptor–ligand associations. We used DPD simulations that allowed us to model the spontaneous adhesion processes at the molecular level, accounting for important factors such as the ligand–receptor binding strength, tether conformation, nanoparticle structural re-organization, receptor re-distribution, and membrane deformation. Major conclusions that have emerged from the simulations include the following: first, the adhesion process follows a pseudo-first-order kinetics (Fig. 4, Table 2), similar to a previous observation on the membrane adhesion of ligand-tethered polymeric micelles.22 Second, similar to ligand-tethered liposomes,34 lipid fluidity facilitates receptor–ligand association through the re-distribution of ligands on the nanoparticle surface while tether extension, receptor re-distribution and membrane deformation increase the number of receptor–ligand pairs. Third, the nanoparticle– membrane system is at a dynamic equilibrium involving multiple receptor–ligand association/disassociation events (Fig. 7 and 8). In short, multivalent binding and geometric confinement together enhance the stability of individual receptor–ligand pairs and overall avidity.

These results offer a unique mechanistic insight into how ligand-tethered LPH nanoparticles bind to pathogenic cell membranes.1 They also suggest that high affinity and specificity may be achieved even at relatively low tether grafting density, which is desirable to avoid an excessively long in vivo circulation time after intravascular administration.8 It is worth noting, however, that membrane adhesion of ligand-tethered nanoparticles is a function of multiple parameters, such as particle size, tether grafting density, tether length and flexibility, and the biophysical characteristics of the targeting systems.37 Following adhesion, endocytosis of receptor-bound nanoparticles is a critical step for drug delivery. This process can also be studied by DPD simulations.40,41 We are currently investigating the relative role of the various design parameters (discussed throughout this paper) on both targeting and engulfment in order to develop a set of rules that can guide efforts toward a systematic optimization of LPH nanoparticles.

Acknowledgments

This work was supported in part by a start-up fund from the University of Texas Medical School at Houston. We thank the Innovation for Cancer Prevention Research (ICPR) postdoctoral fellowship by the UThealth School of Public Health and Cancer Prevention and Research Institute of Texas (CPRIT, grant number: RP101503) for financial support, and the Texas Advanced Computing Center (TACC) for computational resources.

Footnotes

Disclaimer

The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agency.

Contributor Information

Zhenlong Li, Email: zhenlong.li@uth.tmc.edu.

Alemayehu A. Gorfe, Email: alemayehu.a.gorfe@uth.tmc.edu.

Notes and references

  • 1.Zhang L, Chan JM, Gu FX, Rhee J-W, Wang AZ, Radovic-Moreno AF, Alexis F, Langer R, Farokhzad OC. ACS Nano. 2008;2:1696–1702. doi: 10.1021/nn800275r. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Salvador-Morales C, Zhang L, Langer R, Farokhzad OC. Biomaterials. 2009;30:2231–2240. doi: 10.1016/j.biomaterials.2009.01.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Zhang L, Zhang L. Nano LIFE. 2010;1:163–173. [Google Scholar]
  • 4.Hu C-MJ, Kaushal S, Cao HST, Aryal S, Sartor M, Esener S, Bouvet M, Zhang L. Mol. Pharm. 2010;7:914–920. doi: 10.1021/mp900316a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Fang RH, Chen KN, Aryal S, Hu C-MJ, Zhang K, Zhang L. Langmuir. 2012;28:13824–13829. doi: 10.1021/la303012x. [DOI] [PubMed] [Google Scholar]
  • 6.Kim Y, Lee Chung B, Ma M, Mulder WJ, Fayad ZA, Farokhzad OC, Langer R. Nano Lett. 2012;12:3587–3591. doi: 10.1021/nl301253v. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Mandal B, Bhattacharjee H, Mittal N, Sah H, Balabathula P, Thoma LA, Wood GC. Nanomedicine. 2013;9:474–491. doi: 10.1016/j.nano.2012.11.010. [DOI] [PubMed] [Google Scholar]
  • 8.Byrne JD, Betancourt T, Brannon-Peppas L. Adv. Drug Delivery Rev. 2008;60:1615–1626. doi: 10.1016/j.addr.2008.08.005. [DOI] [PubMed] [Google Scholar]
  • 9.Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nat. Nanotechnol. 2007;2:751–760. doi: 10.1038/nnano.2007.387. [DOI] [PubMed] [Google Scholar]
  • 10.Haun JB, Hammer DA. Langmuir. 2008;24:8821–8832. doi: 10.1021/la8005844. [DOI] [PubMed] [Google Scholar]
  • 11.Gunnarsson A, Dexlin L, Wallin P, Svedhem S, Jönsson P, Wingren C, Höök F. J. Am. Chem. Soc. 2011;133:14852–14855. doi: 10.1021/ja2047039. [DOI] [PubMed] [Google Scholar]
  • 12.Hong S, Leroueil PR, Majoros IJ, Orr BG, Baker JR, Jr, Banaszak Holl MM. Chem. Biol. 2007;14:107–115. doi: 10.1016/j.chembiol.2006.11.015. [DOI] [PubMed] [Google Scholar]
  • 13.Tassa C, Duffner JL, Lewis TA, Weissleder R, Schreiber SL, Koehler AN, Shaw SY. Bioconjugate Chem. 2009;21:14–19. doi: 10.1021/bc900438a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Wilhelm C, Gazeau F, Roger J, Pons J, Bacri J-C. Langmuir. 2002;18:8148–8155. [Google Scholar]
  • 15.Ghaghada KB, Saul J, Natarajan JV, Bellamkonda RV, Annapragada AV. J. Controlled Release. 2005;104:113–128. doi: 10.1016/j.jconrel.2005.01.012. [DOI] [PubMed] [Google Scholar]
  • 16.Decuzzi P, Ferrari M. Biomaterials. 2008;29:377–384. doi: 10.1016/j.biomaterials.2007.09.025. [DOI] [PubMed] [Google Scholar]
  • 17.Decuzzi P, Pasqualini R, Arap W, Ferrari M. Pharm. Res. 2009;26:235–243. doi: 10.1007/s11095-008-9697-x. [DOI] [PubMed] [Google Scholar]
  • 18.Agrawal NJ, Radhakrishnan R. J. Phys. Chem. C. 2007;111:15848–15856. doi: 10.1021/jp074514x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Liu J, Weller GE, Zern B, Ayyaswamy PS, Eckmann DM, Muzykantov VR, Radhakrishnan R. Proc. Natl. Acad. Sci. U. S. A. 2010;107:16530–16535. doi: 10.1073/pnas.1006611107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Liu J, Bradley R, Eckmann DM, Ayyaswamy PS, Radhakrishnan R. Curr. Nanosci. 2011;7:727. doi: 10.2174/157341311797483826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Chen CC, Dormidontova EE. Langmuir. 2005;21:5605–5615. doi: 10.1021/la047109v. [DOI] [PubMed] [Google Scholar]
  • 22.Djohari H, Dormidontova EE. Biomacromolecules. 2009;10:3089–3097. doi: 10.1021/bm900785c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Wang S, Dormidontova EE. Phys. Rev. Lett. 2012;109:238102. doi: 10.1103/PhysRevLett.109.238102. [DOI] [PubMed] [Google Scholar]
  • 24.Jeppesen C, Wong JY, Kuhl TL, Israelachvili JN, Mullah N, Zalipsky S, Marques CM. Science. 2001;293:465–468. doi: 10.1126/science.293.5529.465. [DOI] [PubMed] [Google Scholar]
  • 25.Hoogerbrugge P, Koelman J. Europhys. Lett. 1992;19:155. [Google Scholar]
  • 26.Groot RD, Warren PB. J. Chem. Phys. 1997;107:4423. [Google Scholar]
  • 27.Ortiz V, Nielsen SO, Discher DE, Klein ML, Lipowsky R, Shillcock J. J. Phys. Chem. B. 2005;109:17708–17714. doi: 10.1021/jp0512762. [DOI] [PubMed] [Google Scholar]
  • 28.Hu J, Lipowsky R, Weikl TR. Proc. Natl. Acad. Sci. U. S. A. 2013;110:15283–15288. doi: 10.1073/pnas.1305766110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.De Meyer FJ-M, Venturoli M, Smit B. Biophys. J. 2008;95:1851–1865. doi: 10.1529/biophysj.107.124164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Schlijper A, Hoogerbrugge P, Manke C. J. Rheol. 1995;39:567–579. [Google Scholar]
  • 31.Spenley N. Europhys. Lett. 2000;49:534. [Google Scholar]
  • 32.Li Z, Dormidontova EE. Macromolecules. 2010;43:3521–3531. [Google Scholar]
  • 33.Li Z, Gorfe AA. J. Phys. Chem. B. 2014;30:9028–9036. doi: 10.1021/jp5042525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Moore NW, Kuhl TL. Biophys. J. 2006;91:1675–1687. doi: 10.1529/biophysj.105.079871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Plimpton S. J. Comput. Phys. 1995;117:1–19. [Google Scholar]
  • 36.Humphrey W, Dalke A, Schulten K. J. Mol. Graphics. 1996;14:33–38. doi: 10.1016/0263-7855(96)00018-5. [DOI] [PubMed] [Google Scholar]
  • 37.Wang B, Galliford CV, Low PS. Nanomedicine. 2014;9:313–330. doi: 10.2217/nnm.13.175. [DOI] [PubMed] [Google Scholar]
  • 38.De Gennes PG. Scaling concepts in polymer physics. Cornell University Press; 1979. [Google Scholar]
  • 39.Reynwar BJ, Illya G, Harmandaris VA, Müller MM, Kremer K, Deserno M. Nature. 2007;447:461–464. doi: 10.1038/nature05840. [DOI] [PubMed] [Google Scholar]
  • 40.Ding HM, Tian WD, Ma YQ. ACS Nano. 2012;6:1230–1238. doi: 10.1021/nn2038862. [DOI] [PubMed] [Google Scholar]
  • 41.Yang K, Ma YQ. Nat. Nanotechnol. 2010;5:579–583. doi: 10.1038/nnano.2010.141. [DOI] [PubMed] [Google Scholar]

RESOURCES